Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 13;133(24):2615-2618.
doi: 10.1182/blood.2019000406. Epub 2019 Apr 19.

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Affiliations

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Nathanael R Fillmore et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: S.V.Y. receives research funding from Takeda and Celgene. G.R. is a consultant for Celgene, Incyte, and Gilead. M.B. receives research funding from Novartis. N.C.M. is a consultant for Celgene and Takeda and on the board of directors for OncoPep. The remaining authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
OS is shown (in years) for the full cohort and stratified at age <65 and ≥65 years at MM diagnosis. For the full cohort (A), median OS is 5.07 years for AAs and 4.52 years for whites (log-rank P < .001). For <65 years (B), median OS is 7.07 years for AAs and 5.83 years for whites (log-rank P < .001). For ≥65 years (C), median OS is 3.69 years for AAs and 4.04 years for whites (log-rank P = .63).

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. - PubMed
    1. Noone A, Howlader N, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. https://seer.cancer.gov/csr/1975_2015/. Accessed 1 December 2018.
    1. Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic malignancies. Blood. 2017;130(15):1699-1705. - PMC - PubMed
    1. Smith CJ, Ambs S, Landgren O. Biological determinants of health disparities in multiple myeloma. Blood Cancer J. 2018;8(9):85. - PMC - PubMed
    1. Kaya H, Peressini B, Jawed I, et al. . Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients. Int J Hematol. 2012;95(1):64-70. - PubMed

Publication types